Helen of Troy (HELE) Q2 2027 Earnings Call Transcript

Helen of Troy reported fiscal Q2 sales of $440.9 million, up 2.1% year over year, and adjusted diluted EPS of $0.79 versus $0.59 a year earlier; sales were in line with outlook while adjusted EPS, EBITDA and free cash flow exceeded expectations. Gross margin rose 800 basis points to 52.2%, including a $26.9 million pretax tariff-refund benefit, while total debt fell $221 million year over year to $672.6 million and net leverage reached 3.0x. The company narrowed full-year sales guidance to $1.768 billion–$1.822 billion and raised adjusted EPS guidance to $3.60–$4.15, including a $0.30–$0.45 after-tax tariff benefit; management cited inflation, Middle East-related supply risks, and softer discretionary demand. Home & Outdoor sales grew 9.2%, but Beauty & Wellness declined 4.5%.

Analysis

HELE’s reported margin/EPS improvement is a poor proxy for run-rate earnings: the tariff-related benefit is concentrated in Q3, while much of the reinvestment is expected later, creating a likely Q4 comparison/earnings air pocket. The key test is whether base-business growth and cash conversion absorb that reversal—not whether the next quarter’s headline EPS beats. Debt paydown lowers financial risk, but it does not resolve weak discretionary demand or the possibility that fuel, freight, and sourcing costs outpace pricing.

The portfolio is bifurcating. Osprey, OXO, Wellness, and Olive & June momentum supports selective investment, but Hydro Flask’s category saturation and channel inventory correction make Home & Outdoor’s Q2 growth a poor straight-line extrapolation. Beauty’s improvement remains early and uneven; a new leader and refreshed innovation pipeline are execution options, not yet evidence of an inflection. Ulta Beauty is a distribution partner for Olive & June, but the available information does not support a material read-through to ULTA earnings.

Near term, tariff recognition can support HELE’s Q3 print; over 1–3 months, watch retailer orders and POS as beverageware inventory clears. Over 6–18 months, supply diversification, packaging changes, and brand investment could improve resilience, but returns may lag and added capex competes with deleveraging. Contrarian point: lower debt and inventory are genuine improvements, yet investors may over-credit a one-off gross-margin boost while underweighting the Q4 reinvestment drag and underlying category softness. No valuation or price data is provided to establish an attractive entry.

Key Decisions for Investors

• Avoid chasing HELE on tariff-inflated Q3 EPS; treat the quarter as a timing benefit and reassess after the company reports Q4 base-business performance.
• Keep HELE on a watchlist rather than forcing a directional position. Consider a long only after evidence that organic sales and base-business margins are stabilizing; use a short/underweight thesis if beverageware POS and retailer orders deteriorate further.
• Track three falsifiers/catalysts: active inventory improvement toward management’s stated year-end target, base-business EPS and free-cash-flow delivery, and progress toward the leverage goal. Failure on inventory or cash conversion would weaken the recovery thesis.
• Monitor fuel/freight and supply disruption alongside gross margin; renewed cost acceleration without pricing recovery would make the tariff-funded margin rebound less durable.